IPHA News
July 3, 2023
Last Friday, June 30th, IPHA published the Transfer of value (ToV) Disclosure data for 2022. The total ToV amount for 2022 was €26,140,927 which is a […]
April 28, 2023
In 2022, it took on average 567 days from EMA authorisation to availability to patients of new innovative medicines in Ireland, among the slowest in western […]
March 15, 2023
The Irish Pharmaceutical Healthcare Association (IPHA) is pleased to announce the appointment of Eimear O’Leary, PhD as Director of Communications and Advocacy. Eimear previously held the […]
March 2, 2023
Irish Pharmaceutical Healthcare Association Annual Conference An Tánaiste, Micheál Martin TD Thank you Michael for your very warm and suspiciously complimentary introduction. And good evening ladies […]
March 2, 2023
Irish Pharmaceutical Healthcare Association (IPHA) Annual Conference, Mansion House Dublin, March 2, 2023. Good morning, I’m delighted to join you at your annual conference. I’d like […]
March 2, 2023
Annual Conference to assess innovation pipeline and supportive policies Proposals from the European Commission to weaken intellectual property rights will degrade the development and delivery of […]
February 24, 2023
The decision by Minister for Health, Stephen Donnelly T.D. to publish the Mazars Report today has been welcomed by the Irish Pharmaceutical Healthcare Association as a […]
December 5, 2022
61% would follow doctor’s advice on vaccination 51% have received two or more booster Covid-19 vaccine doses 77% believe children should study science at school Almost […]
November 7, 2022
IPHA urges Government to heed slide in Europe’s research and development investments and clinical trials activity as policymakers in Brussels weigh legislative changes Europe could lose […]